Lyell Immunopharma Cash Flow Statement (2019-2025) | LYEL

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2019 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -30.66M-35.75M-38.90M-55.02M-62.49M-48.89M-47.22M-68.18M-36.31M-64.19M-11.33M-58.06M-60.64M-52.43M-52.42M-48.76M-45.16M-44.54M-196.23M-53.51M-43.86M-33.99M
Share-based Compensation 3.27M9.75M12.97M12.73M15.25M13.04M21.18M22.03M22.41M19.12M18.36M13.88M14.22M10.52M8.46M9.15M8.28M7.62M8.08M6.02M5.00M5.23M
Gains from Sales and Divestitures 2.99M3.97M
Gains from Investment Securities 7.00M0.04M0.11M0.04M36.25M-0.03M5.00M10.00M2.92M13.00M
Asset Writedowns and Impairment 36.45M5.00M-5.00M51.30M
Non-cash Items 23.16M24.40M
Cash from Operations -21.63M-26.73M-33.60M-33.95M-25.49M-33.21M-47.85M-44.33M-37.10M-40.27M-46.21M-39.16M-37.69M-40.63M-42.02M-38.09M-35.04M-47.24M-54.74M-34.46M-28.58M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles -0.18M-0.47M-0.48M-0.40M-0.55M-0.47M-0.47M-0.23M0.43M1.21M1.85M2.08M2.29M3.38M4.37M3.76M3.59M2.96M1.73M1.17M1.01M
Depreciation & Amortization (CF) 1.10M1.45M1.96M3.01M4.09M4.57M4.19M4.17M4.62M5.04M5.03M5.06M5.10M5.06M5.02M4.90M4.68M5.03M3.44M3.13M2.57M
Change in Working Capital
Change in Account Payables -0.29M0.34M0.63M0.35M-0.99M0.10M2.94M-1.77M0.02M-0.53M2.07M0.38M-1.41M0.42M-0.11M-0.52M-0.57M-2.04M-1.65M-0.23M-0.78M
Change in Accured Expenses 0.85M1.91M-4.70M3.08M1.94M4.22M-6.39M-0.77M1.32M5.37M-5.86M2.27M4.61M-1.74M-3.61M0.52M3.09M-1.25M-9.79M-3.33M0.57M
Investing Activities
Capital Expenditures 12.64M24.88M19.19M24.45M11.60M10.27M9.73M7.17M2.79M4.58M1.53M0.93M0.20M0.03M0.22M0.14M0.06M0.04M0.25M0.17M0.06M
Change in Acquisitions & Divestments 173.10M205.69M204.16M200.87M142.04M70.33M79.81M121.85M106.50M110.90M142.25M187.10M178.15M156.12M130.03M161.80M133.41M123.70M154.12M93.52M74.14M
Cash from Investing Activities -89.94M32.39M136.68M-39.47M-144.91M-73.86M-26.12M25.02M-57.09M46.65M32.15M152.91M99.67M-100.69M21.99M45.01M1.92M53.51M69.47M12.65M3.35M
Financing Activities
Change in Capital Stock
Shares Issued 0.04M0.34M0.88M391.80M-1.06M2.56M1.57M5.13M0.33M1.16M0.73M0.10M0.71M0.44M0.18M49.82M
Misc.
Cash from Financing Activities 0.04M0.34M0.88M393.49M-0.53M7.40M2.56M2.46M4.76M0.86M-0.07M1.20M-0.14M0.76M0.03M0.86M0.44M0.00M0.18M50.00M
Change in Cash -111.54M5.99M103.96M320.07M-170.94M-99.68M-71.42M-16.86M-89.43M7.24M-14.13M114.95M61.84M-140.57M-20.00M7.78M-33.12M6.70M14.73M-21.63M24.77M
Beginning Cash Balance 96.67M246.42M246.42M134.41M140.41M244.37M564.44M393.50M294.01M222.60M205.74M116.31M123.55M109.42M224.37M286.21M145.65M125.65M133.42M98.90M105.60M120.43M98.80M
Free Cash Flow -34.27M-51.61M-52.79M-58.39M-37.09M-43.48M-57.59M-51.50M-39.89M-44.85M-47.74M-40.09M-37.88M-40.66M-42.24M-38.23M-35.10M-47.29M-54.98M-34.63M-28.64M
Net Cash Flow -111.54M5.99M103.96M320.07M-170.94M-99.68M-71.42M-16.86M-89.43M7.24M-14.13M114.95M61.84M-140.57M-20.00M7.78M-33.12M6.70M14.73M-21.63M24.77M